Successful treatment of scleromyxedema with plasmapheresis and immunosuppression

Effect of commercial prescription diets containing prebiotics on clinical signs and fecal microbiome in dogs with intestinal disease.

Polish journal of veterinary sciences·2024

Comparison of traditional two-injection dorsal digital block versus transthecal and subcutaneous single-injection digital block: A systematic review and meta-analysis.

Hand surgery & rehabilitation·2021

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

SU-E-T-648: Comparison of VMAT Vs Arc Treatment Plans for Patients Undergoing SBRT of Early-Stage Non-Small Cell Lung Cancer (NSCLC).

Medical physics·2017

SU-D-213CD-03: Live Video-Guided Volumetric Tracking of Respiration Motion.

Medical physics·2017

Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma.

Oncogenesis·2016

Nail disorders in pediatric patients: Part 1. Clinical overview, diagnosis and management of physiological variants, and congenital, hereditary, and infectious etiologies.

Journal of the American Academy of Dermatology·2026

Psoriasis: Which therapy for which patient, updated, part I. Focus on Psoriasis Comorbidities and Preferred Systemic Agents.

Journal of the American Academy of Dermatology·2026

Nail disorders in pediatric patients: Part 2. Clinical overview, diagnosis and management of inflammatory, pigmentary, and neoplastic etiologies.

Journal of the American Academy of Dermatology·2026

Efficacy and safety of litifilimab in cutaneous lupus erythematosus: 24-week results of the randomized phase 2 study, AMETHYST.

Journal of the American Academy of Dermatology·2026

Pembrolizumab-Associated Adrenal Insufficiency Presenting as Adrenal Crisis: A Case Report.

Cureus·2026

Engineering immune cell engagers: From molecular constructs to biomaterial platforms.

Materials today. Bio·2026

Disseminated Tuberculosis With Ocular Involvement After 12 Years of Anti-TNF-α Therapy.

Case reports in ophthalmological medicine·2026

Effects of intensive insulin therapy combined with non-insulin antihyperglycemic agents on glycemic control, variability, and metabolic outcomes in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Frontiers in endocrinology·2026

Genetically Defined Acute Myeloid Leukemia Induced Pluripotent Stem Cell Clones Reveal Selective Impairment of Hematopoietic Development.

Stem cells and development·2026

Off-Label Use of Monoclonal Antibodies in Developing Countries.

American journal of therapeutics·2026

Related Experiment Videos

Successful treatment of scleromyxedema with plasmapheresis and immunosuppression

Related Concept Videos

Effect of commercial prescription diets containing prebiotics on clinical signs and fecal microbiome in dogs with intestinal disease.

Comparison of traditional two-injection dorsal digital block versus transthecal and subcutaneous single-injection digital block: A systematic review and meta-analysis.

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.

SU-E-T-648: Comparison of VMAT Vs Arc Treatment Plans for Patients Undergoing SBRT of Early-Stage Non-Small Cell Lung Cancer (NSCLC).

SU-D-213CD-03: Live Video-Guided Volumetric Tracking of Respiration Motion.

Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma.

Nail disorders in pediatric patients: Part 1. Clinical overview, diagnosis and management of physiological variants, and congenital, hereditary, and infectious etiologies.

Psoriasis: Which therapy for which patient, updated, part I. Focus on Psoriasis Comorbidities and Preferred Systemic Agents.

Nail disorders in pediatric patients: Part 2. Clinical overview, diagnosis and management of inflammatory, pigmentary, and neoplastic etiologies.

Efficacy and safety of litifilimab in cutaneous lupus erythematosus: 24-week results of the randomized phase 2 study, AMETHYST.

Pembrolizumab-Associated Adrenal Insufficiency Presenting as Adrenal Crisis: A Case Report.

Engineering immune cell engagers: From molecular constructs to biomaterial platforms.

Disseminated Tuberculosis With Ocular Involvement After 12 Years of Anti-TNF-α Therapy.

Effects of intensive insulin therapy combined with non-insulin antihyperglycemic agents on glycemic control, variability, and metabolic outcomes in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Genetically Defined Acute Myeloid Leukemia Induced Pluripotent Stem Cell Clones Reveal Selective Impairment of Hematopoietic Development.

Off-Label Use of Monoclonal Antibodies in Developing Countries.

Related Experiment Videos

Successful treatment of scleromyxedema with plasmapheresis and immunosuppression

Related Concept Videos

Related Articles